First, the authors demonstrated that CRC patients with distant lymph node metastasis were significantly associated with high levels of HLA-G, ILT-2, ILT-4, and PD-L1, thus suggesting that all these molecules are related to a worse prognosis. The gene discussed is LILRB2; the disease is colorectal carcinoma.